549 related articles for article (PubMed ID: 18787906)
1. Does the presence of circulating tumor cells in the venous drainage of curative colorectal cancer resections determine prognosis? A meta-analysis.
Katsuno H; Zacharakis E; Aziz O; Rao C; Deeba S; Paraskeva P; Ziprin P; Athanasiou T; Darzi A
Ann Surg Oncol; 2008 Nov; 15(11):3083-91. PubMed ID: 18787906
[TBL] [Abstract][Full Text] [Related]
2. Detection of survivin-expressing circulating cancer cells (CCCs) in peripheral blood of patients with gastric and colorectal cancer reveals high risks of relapse.
Yie SM; Lou B; Ye SR; Cao M; He X; Li P; Hu K; Rao L; Wu SM; Xiao HB; Gao E
Ann Surg Oncol; 2008 Nov; 15(11):3073-82. PubMed ID: 18670822
[TBL] [Abstract][Full Text] [Related]
3. Can intra-operative intraperitoneal free cancer cell detection techniques identify patients at higher recurrence risk following curative colorectal cancer resection: a meta-analysis.
Rekhraj S; Aziz O; Prabhudesai S; Zacharakis E; Mohr F; Athanasiou T; Darzi A; Ziprin P
Ann Surg Oncol; 2008 Jan; 15(1):60-8. PubMed ID: 17909914
[TBL] [Abstract][Full Text] [Related]
4. Usefulness and clinical significance of quantitative real-time RT-PCR to detect isolated tumor cells in the peripheral blood and tumor drainage blood of patients with colorectal cancer.
Iinuma H; Okinaga K; Egami H; Mimori K; Hayashi N; Nishida K; Adachi M; Mori M; Sasako M
Int J Oncol; 2006 Feb; 28(2):297-306. PubMed ID: 16391782
[TBL] [Abstract][Full Text] [Related]
5. Detection of circulating gastric cancer cells in peripheral blood using real time quantitative RT-PCR.
Koga T; Tokunaga E; Sumiyoshi Y; Oki E; Oda S; Takahashi I; Kakeji Y; Baba H; Maehara Y
Hepatogastroenterology; 2008; 55(84):1131-5. PubMed ID: 18705345
[TBL] [Abstract][Full Text] [Related]
6. Detection of carcinoembryonic antigen messenger RNA-expressing cells in peripheral blood 7 days after curative surgery is a novel prognostic factor in colorectal cancer.
Sadahiro S; Suzuki T; Maeda Y; Yurimoto S; Yasuda S; Makuuchi H; Kamijo A; Murayama C
Ann Surg Oncol; 2007 Mar; 14(3):1092-8. PubMed ID: 17200912
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of reverse transcriptase-polymerase chain reaction measurement of carcinoembryonic antigen mRNA levels in tumor drainage blood and peripheral blood of patients with colorectal carcinoma.
Taniguchi T; Makino M; Suzuki K; Kaibara N
Cancer; 2000 Sep; 89(5):970-6. PubMed ID: 10964326
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
[TBL] [Abstract][Full Text] [Related]
9. Identification of early-stage colorectal cancer patients at risk of relapse post-resection by immunobead reverse transcription-PCR analysis of peritoneal lavage fluid for malignant cells.
Lloyd JM; McIver CM; Stephenson SA; Hewett PJ; Rieger N; Hardingham JE
Clin Cancer Res; 2006 Jan; 12(2):417-23. PubMed ID: 16428481
[TBL] [Abstract][Full Text] [Related]
10. Lack of prognostic influence of circulating tumor cells in peripheral blood of patients with colorectal cancer.
Bessa X; Elizalde JI; Boix L; Piñol V; Lacy AM; Saló J; Piqué JM; Castells A
Gastroenterology; 2001 Apr; 120(5):1084-92. PubMed ID: 11266372
[TBL] [Abstract][Full Text] [Related]
11. Correlation of circulating angiogenic factors with circulating tumor cells and disease recurrence in patients undergoing curative resection for colorectal liver metastases.
Rahbari NN; Reissfelder C; Mühlbayer M; Weidmann K; Kahlert C; Büchler MW; Weitz J; Koch M
Ann Surg Oncol; 2011 Aug; 18(8):2182-91. PubMed ID: 21598056
[TBL] [Abstract][Full Text] [Related]
12. Role of circulating tumour cells in predicting recurrence after excision of primary colorectal carcinoma.
Allen-Mersh TG; McCullough TK; Patel H; Wharton RQ; Glover C; Jonas SK
Br J Surg; 2007 Jan; 94(1):96-105. PubMed ID: 17058316
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of putative circulating cancer stem cells in patients undergoing hepatic resection for colorectal liver metastasis.
Pilati P; Mocellin S; Bertazza L; Galdi F; Briarava M; Mammano E; Tessari E; Zavagno G; Nitti D
Ann Surg Oncol; 2012 Feb; 19(2):402-8. PubMed ID: 22071867
[TBL] [Abstract][Full Text] [Related]
14. Persistent presence of postoperative circulating tumor cells is a poor prognostic factor for patients with stage I-III colorectal cancer after curative resection.
Uen YH; Lu CY; Tsai HL; Yu FJ; Huang MY; Cheng TL; Lin SR; Wang JY
Ann Surg Oncol; 2008 Aug; 15(8):2120-8. PubMed ID: 18481151
[TBL] [Abstract][Full Text] [Related]
15. Heparanase expression in human colorectal cancer and its relationship to tumor angiogenesis, hematogenous metastasis, and prognosis.
Sato T; Yamaguchi A; Goi T; Hirono Y; Takeuchi K; Katayama K; Matsukawa S
J Surg Oncol; 2004 Sep; 87(4):174-81. PubMed ID: 15334632
[TBL] [Abstract][Full Text] [Related]
16. Detection of carcinoembryonic antigen messenger RNA-expressing cells in portal and peripheral blood during surgery does not influence relapse in colorectal cancer.
Sadahiro S; Suzuki T; Ishikawa K; Saguchi T; Maeda Y; Yasuda S; Makuuchi H; Yurimoto S; Murayama C
Ann Surg Oncol; 2005 Dec; 12(12):988-94. PubMed ID: 16244799
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of BMP7 in human colorectal cancer.
Motoyama K; Tanaka F; Kosaka Y; Mimori K; Uetake H; Inoue H; Sugihara K; Mori M
Ann Surg Oncol; 2008 May; 15(5):1530-7. PubMed ID: 18259822
[TBL] [Abstract][Full Text] [Related]
18. Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperative serum lactate dehydrogenase level.
Nowecki ZI; Rutkowski P; Kulik J; Siedlecki JA; Ruka W
Br J Dermatol; 2008 Sep; 159(3):597-605. PubMed ID: 18616789
[TBL] [Abstract][Full Text] [Related]
19. Detection of disseminated tumour cells as a potential surrogate-marker for monitoring palliative chemotherapy in colorectal cancer patients.
Staritz P; Kienle P; Koch M; Benner A; von Knebel Doeberitz M; Rudi J; Weitz J
J Exp Clin Cancer Res; 2004 Dec; 23(4):633-9. PubMed ID: 15743034
[TBL] [Abstract][Full Text] [Related]
20. [Cytokeratin 20 as a marker of tumor progression or dissemination in patients with colorectal cancer].
Garrido S M; Ramírez V P; Risueño A C; Orellana U E; Galindo A H; Alvarez Z M
Rev Med Chil; 2008 Apr; 136(4):482-90. PubMed ID: 18769791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
